Fujian Standardizes Oral Price Items; Provinces Must Implement Price Project Guideline Training in H2; Mani’s China Dental Sales Up 49% YoY in First Three Quarters of FY2026; Overseas Dental Chain Op…

Fujian Standardizes 114 Dental Pricing Items, Effective October 15 with a 5-Year Validity Period

On July 21, 2026, Fujian Provincial Healthcare Security Administration issued a "Notice" to uniformly implement 114 dental medical service pricing items across the province starting October 15, 2026, while discontinuing 380 items, with a 5-year implementation period. Items such as orthodontic treatment, root canal therapy, and dental restoration are priced according to the Price Ceiling set by provincial-level tertiary hospitals. Non-public Designated Medical Insurance Institutions must adhere to medical insurance agreements and ensure transparent fee disclosure.

Hong Kong Dental Association: Overseas Dental Chains Suspected of Illegal Practice in Hong Kong

On July 22, 2026, an undercover investigation by the Hong Kong Dental Association (HKDA) found that overseas dental chains have set up consultation points in Hong Kong, suspected of violating the "Dentists Registration Ordinance." A survey of approximately 200 private dentists revealed an average of 4 overseas patients per month, with Dental Implant treatment accounting for 67%. The HKDA also disclosed a case of permanent nerve damage resulting from a dental implant procedure in Shenzhen. The association calls for enhanced cross-border regulatory cooperation between Hong Kong and Macau, revision of regulations on misleading advertisements, and strengthened public oral health education. Founded in 1950, the HKDA has over 2,400 members, representing about 90% of registered dentists in Hong Kong.

Official Announcement | 好的牙（DentalGoodNews） Becomes Official Media Partner of CDS 2026

From October 13 to 16, 2026, the 28th Annual Academic Conference of the Chinese Stomatological Association (CSA) and the 中国国际口腔设备器材博览会 (CDS 2026) will be held at the National Exhibition and Convention Center (Shanghai), co-hosted by the CSA and 国药励展展览有限责任公司 (RSE).

This year's conference coincides with the 30th anniversary of the CSA's founding. It will concurrently hold the quinquennial members' congress to elect a new council. The 20th Academic Conference of the Prosthodontics Committee will also be held at the same venue. Additionally, the conference introduces new special sessions, including a Core Competency Training Camp for Young and Mid-Career Dentists and "Women in Dentistry," providing targeted exchange platforms for different groups.

For this conference, 好的牙（DentalGoodNews） (DGN) has been officially confirmed as the official media partner for CDS 2026. DGN will undertake full-cycle content reporting and multi-channel dissemination before, during, and after the exhibition, with content available to global readers in both Chinese and English.

Sinocera: Zirconia Powder Sales Price to Increase from July 27, Up to 40%

On July 27, 2026, 山东国瓷功能材料股份有限公司 (Sinocera) raised the sales price of its Zirconia powder by approximately 10% to 40%. The company stated that the price increase is expected to boost performance but cautioned that sales volume and the duration of the price increase remain uncertain. Previously, the company applied for a guarantee credit line of up to 700 million yuan to acquire Australian dental materials company SDI Limited.

国家医保局 (NHSA): Provinces Must Complete Training on Published Price Item Guidelines by H2 2026

On July 21, 2026, the 国家医保局 (NHSA) required all provincial healthcare security administrations to complete training on the implementation of published Medical Service Price Item Establishment Guidelines in the second half of 2026. Key points include training at provincial and municipal levels, preparation of local interpretation materials, setting up policy Q&A columns, and industry promotion and interpretation. Training must be conducted for municipal healthcare security departments and provincial-level medical institutions before the new price items take effect, clarifying billing scopes and dynamically updating interpretation materials. Provinces must promptly summarize experiences and report them; the NHSA will select and promote best practices.

Shining3D Tech Co., Ltd.: Dental 3D Scanner Revenue Reaches 940 Million Yuan, Intraoral Scanning Elite Platform Up 519% YoY

On July 22, 2026, 先临三维 (Shining3D Tech Co., Ltd.) released an announcement regarding its application for public listing on the 北交所 (BSE) and a trading halt progress update. On July 21, it disclosed its response to the second round of review inquiries, addressing issues such as revenue growth, gross margin changes, distributor verification, and subsidiary operations. The response document shows that the company's dental 3D scanner revenue in 2025 reached 939 million yuan. The 口扫 (IOS) Elite technology platform product, launched in the second half of 2024, generated 417 million yuan in revenue in 2025, a year-on-year increase of 519.33%, becoming a new driver for dental 3D scanner revenue growth. Previously, on April 20, 2026, the BSE adjusted Shining3D's listing review status back to "under review."

奥精医疗科技股份有限公司 (Allgens Medical Technology Co., Ltd.) Corrects 2025 Annual Report Data: Dental Implant Gross Margin Turns from Decline to Increase

On July 22, 2026, 奥精医疗科技股份有限公司 (Allgens Medical Technology Co., Ltd.) issued a correction to its 2025 annual report, revising the gross margin for its Dental Implant products from a decrease of 39.74 percentage points to an increase of 19.51 percentage points. The product's 2025 operating revenue was 2.7492 million yuan, with a cost of 1.3309 million yuan, resulting in a gross margin of 51.59%. The company attributed the correction to an information verification error, stating that apart from this correction, the rest of the report remains unchanged. It apologized and pledged to strengthen proofreading to improve disclosure quality.

One of Canada's Largest Dental DSOs Expands into the US, First Acquisition in Florida

On July 21, 2026, Dentalcorp completed the acquisition of Northstar Dental Partners, which operates 21 dental clinics in Boca Raton, Florida, marking its entry into the US market. Following the acquisition, its North American support network exceeds 650 locations, with nearly 6 million patient visits annually. Northstar was founded by Jordan Tomalty, originally known as Tomalty Dental Care, and has been expanding through acquisitions since 2022. As of press time, Dentalcorp has not disclosed the transaction amount or financial terms.

Orthodontic Technology Company Alta Smiles Completes Series Seed Extension Financing

On July 23, 2026, orthodontic technology company Alta Smiles completed a Series Seed extension financing round. Run Ventures led the round, with participation from Stokes Stevenson McMaster Health Ventures and additional investment from the Dental Innovation Alliance (DIA). The funds will be used to accelerate the commercialization of the C⁵ hidden orthodontic system and enhance market awareness. The company also appointed Dan McMaster, a former 3M Health Care executive, and Gene Dorff, a former Dentsply Sirona executive, as new directors. As of press time, Alta Smiles has not disclosed the specific amount of this financing round or its latest valuation.

マニ株式会社 (MANI, Inc.) FY2026 First Three Quarters: China Dental Sales Approx. 128 Million RMB, Up 49% YoY

Recently, マニ株式会社 (MANI, Inc.) announced its performance for the first three quarters of fiscal year 2026. Net sales were 24.396 billion yen (approx. 1.095 billion RMB), up 9.5% year-on-year. Operating Profit for the dental segment was 1.473 billion yen (approx. 66.1 million RMB), up 102.4% year-on-year, accounting for 35% of dental sales. Dental sales in China were 2.844 billion yen (approx. 128 million RMB), up approximately 49% year-on-year. The company raised its full-year Net Profit Attributable to Shareholders of the Parent Company forecast to 6.8 billion yen (approx. 305 million RMB), corresponding to earnings per share of 69.03 yen.

Zhejiang Medical Insurance New Policy: Accelerated Access for Innovative Drugs and Medical Devices to 10 Working Days, DRG Incentives Implemented

Recently, the Zhejiang Provincial Healthcare Security Administration issued "Measures" to compress the approval timeline for listing Innovative drugs and medical devices to no more than 10 working days. It simultaneously introduced DRG Payment incentives and financial subsidies of up to 30 million yuan to encourage the rapid market entry of innovative drugs and devices in fields including dentistry. The policy also clarifies a Special case review ratio not exceeding 2‰, a Three Exclusions mechanism, and a Dual channel mechanism management, ensuring a 100% direct settlement rate for VBP (Volume-Based Procurement) products. The document focuses on implementing medical insurance payment reforms and accelerating the application of innovative pharmaceuticals and medical devices.

US House Passes "Oral Health Action Act," Allocating $15 Million Annually to Alleviate Dental Workforce Shortage

On July 20, 2026, the US House of Representatives passed the bipartisan "Oral Health Action Act," which allocates $15 million annually through fiscal year 2030 to support training, recruitment, and mobile services in areas with dental workforce shortages. On July 23, Senators Cory Booker and Ted Budd introduced a companion version in the Senate, proposing to extend the authorization through fiscal year 2031. The bill aims to improve access to oral care in underserved areas. The subsequent review process for the Senate companion version is still pending.

New Data: Highest Annual Salary for US Dental Specialists Reaches $470,000, Approximately 1.7-2.5 Times That of General Dentists

In May 2025, data from the US Bureau of Labor Statistics showed that Oral Surgery specialists in Pennsylvania earned an average annual salary of $473,110, approximately 9.75 times the local cost of living of $48,515. The average annual salary in North Carolina was $330,620. Orthodontists in Connecticut earned an average annual salary of $412,100, about 7.6 times the cost of living of $54,178. Cost of living data is referenced from the MIT Living Wage Calculator.

New Data: Female Applicants, Enrollment, and Graduates in US Dental Schools Now Outnumber Males

A longitudinal study published recently in the "Journal of the 美国牙科协会 (ADA)" shows that over the past 14 years, women have outnumbered men among applicants, first-year students, and graduates in US predoctoral dental education. In the 2024-2025 academic year, women comprised 58.1% of applicants and 58.0% of first-year students, with the representation ratio (PR) rising to 1.15. For the most recent available 2023-2024 academic year, women accounted for 55.8% of graduates, with a PR of 1.10. The increase in female applicants was 34.6% at private institutions, higher than at public institutions. The study suggests that the rising proportion of female dentists may help improve access to oral healthcare for minority and underserved populations.

FDI (World Dental Federation) Releases Decade Data Report: 29.0% of Chinese Respondents Affected by Oral Appearance in Job Interviews

On July 17, 2026, the FDI released a report titled "OHO (Oral Health Observatory) Decade Data," showing that 88.6% of dental patients in China have no Dental insurance, the rate of Periodontal disease reaches 62.2%, and 29.0% of respondents reported that their oral appearance affected their job interviews. The report reiterates the necessity of strengthening professional Periodontal care and integrating OHO data with national health information systems.

Sichuan University Team Uses AI to Screen Hydrogels for Periodontitis Treatment; Mouse Model Performance Comparable to Minocycline

Recently, a team led by Zhao Hang from Sichuan University used machine learning to screen 7,257 nucleoside derivatives. Based on nine bioactivity datasets, they identified two Nucleoside hydrogels, GMP (Good Manufacturing Practice) and dGMP (2'-Deoxyguanosine monophosphate). Experiments showed that in a mouse model of Periodontitis, these hydrogels exhibited self-healing and shear-thinning properties, demonstrated antibacterial and anti-inflammatory effects, and significantly protected alveolar bone, with therapeutic effects comparable to Minocycline (MINO). The team noted that this AI-driven framework improves screening efficiency but still requires clinical human trials.